👁️image loading
(from DailyMed)

GenTeal Tears Moderate Preservative Free dextran 70, hypromellose 2910 2910 (4000 MPA.S) 3 mg/mL; 70 1 mg/mL Solution/ Drops, 36 vials — NDC 0065-8063-01 (Billing 00065-8063-01)

by Alcon Laboratories, Inc. · 36 VIAL, SINGLE-DOSE in 1 CARTON / .9 mL in 1 VIAL, SINGLE-DOSE

This is a package of 36 vials of GenTeal Tears Moderate Preservative Free dextran 70, hypromellose 2910 2910 (4000 MPA.S) 3 mg/mL; 70 1 mg/mL Solution/ Drops from Alcon Laboratories, Inc., marketed since Jul 2018 and currently FDA-listed; retail pharmacies pay about $0.2997 per vial (NADAC). It is this product's only package size.

NDC 00065-8063-01
🏷️ FDA NDC (as labeled) 0065-8063-01 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0065-8063-01
Product NDC 0065-8063
11-digit billing NDC 00065806301
NCPDP billing unit EA — each (per item)
RxCUI 309714
UNII RN3152OP35, 7SA290YK68
Application # M018
SPL Set ID 37686e54-e64d-47c8-b082-b944a23cf6f1
Established class (EPC) Plasma Volume Expander
Mechanism of action Osmotic Activity
Physiologic effect Increased Intravascular Volume
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-07-03
Route OPHTHALMIC
Dosage form SOLUTION/ DROPS
Substance HYPROMELLOSE 2910 (4000 MPA.S); DEXTRAN 70

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 86209902242025
GPI class GenTeal Tears Moderate PF
GCN Seq No 063562
GCN 99284
HICL code 036551
Ingredient (HICL) Dextran 70/Hypromellose/Pf
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q6
Therapeutic class — intermediate (HIC2) Ophthalmic Preparations
HIC3 code Q6T
Therapeutic class — specific (HIC3) Artificial Tears
AHFS code 52:92.00.00
AHFS class Eent Drugs, Miscellaneous
FDB label name GENTEAL TEARS 0.1%-0.3% DROP
FDB brand name Genteal Tears
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 063562
  • GCN: 99284
  • GPI-14 (Medi-Span): 86209902242025
  • HICL (First Databank): 036551
  • AHFS class code: 52:92.00.00
  • RxCUI (RxNorm): 309714
Why two NDCs? The FDA registers this code as 0065-8063-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00065-8063-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Viscoelastic substances class.

Drug family (ATC) Viscoelastic substances
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name GENTEAL TEARS 0.1%-0.3% DROP Ingredient Dextran 70/Hypromellose/Pf
🧪 What is this product?

GenTeal Tears Moderate is a preservative-free eye drop solution containing dextran 70 and hypromellose. These ingredients function as lubricants and are typically used to relieve dry eye discomfort by helping to coat and moisten the eye surface. This is an over-the-counter monograph product, meaning it is marketed under FDA's established rules for eye lubricant drops rather than as an individually reviewed application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.300 $10.79 / 36 vials
Medicaid paysCMS SDUD · 12 mo $0.4833 $17.40 / 36 vials
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Aug 2021 Feb 2024 Apr 2026 Sep 2026 $0.305 $0.278
▲ Up 8% over the last 15 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00065-8063-01 You're viewing this Main listing 36 VIAL, SINGLE-DOSE in 1 CARTON / .9 mL in 1 VIAL, SINGLE-DOSE 2018-07-03 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
GenTeal Tears Moderate Preservative Free 2910 (4000 MPA.S) 3 mg/mL; 70 1 mg/mLthis 00065-8063-01 Alcon 36 vials $0.300 — Availability likely —
Bion Tears 70 1 mg/mL; 2910 (4000 MPA.S) 3 mg/mL 00065-9305-01 Alcon 28 vials $0.473 — FDA listed +58%
Walgreens Lubricant Eye Drops Preservative Free 70 .1 g/100mL; .3 g/100mL 00363-0646-01 Walgreen 35 vials — — FDA listed —
CVS Gentle Tears .3 g/100mL; 70 .1 g/100mL 69842-0474-01 CVS 35 vials — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Jul 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII 660YQ98I10
    Potassium chloride is a mineral salt used in medicines as a buffer and to help maintain the proper pH balance and stability of the formulation during storage and use.
  • UNII 91MBZ8H3QO
    Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statespotassium chloride, purified water, sodium borate, sodium chloride. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAlcon Laboratories, Inc.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code00065
First marketedJul 2018
Product typeHuman Otc Drug
Portfolio55 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words ▾

Uses temporary relief of discomfort due to minor irritations of the eye, or to exposure to wind or sun

⏱️ Dosage and Administration 12 words ▾

Directions put 1 or 2 drops in the affected eye(s) as needed.

⚠️ Warnings 5 words ▾

Warnings For external use only

🧪 Active Ingredient 11 words ▾

Active Ingredients Purpose Dextran 70 0.1% Lubricant Hypromellose 2910 0.3% Lubricant

🧪 Inactive Ingredients 20 words ▾

Inactive ingredients potassium chloride, purified water, sodium borate, sodium chloride. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

🎯 Purpose 11 words ▾

Active Ingredients Purpose Dextran 70 0.1% Lubricant Hypromellose 2910 0.3% Lubricant

📄 Do Not Use 21 words ▾

Do not use if this solution changes color or becomes cloudy if you are sensitive to any ingredient in this product

📄 When Using This Product 22 words ▾

When using this product to avoid contamination, do not touch tip of container to any surface do not reuse once opened, discard

📄 Stop Use and Ask a Doctor If 34 words ▾

Stop use and ask a doctor if you experience any of the following: eye pain changes in vision continued redness or irritation of the eye condition worsens or persists for more than 72 hours

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 18 words ▾

Other information store are room temperature 15 o – 25 o C (59 o – 77 o F)

📄 Questions or Comments 12 words ▾

Questions? In the U.S. call 1 (800) 757-9195 (Mon-Fri 9AM-5PM CST) [email protected]

📄 Package Label / Principal Display Panel 92 words ▾

PRINCIPAL DISPLAY PANEL PRESERVATIVE FREE Moderate DRY EYE SYMPTOM RELIEF GenTeal ® Tears LUBRICANT EYE DROPS LIQUID DROPS Fast, Soothing Relief Preservative Free Formula Previously TEARS NATURALE ® FREE LUBRICANT EYE DROPS STERILE 36 Single-Use Vials 0.9 mL (0.03 FL OZ) Each Alcon GenTeal ® Tears Lubricant Eye Drops Preservative Free provide lasting relief for moderate dry eye with the convenience of a vial. TAMPER EVIDENTY: Do not use if vial is damaged or opened. Distributed by: Alcon Laboratories, Inc., 6201 South Freeway Fort Worth, Texas 76134 Country of Origin: France 435581

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
10.6K
Units reimbursed last 4 qtrs
434K
Gross reimbursed last 4 qtrs
$209.7K
Avg / prescription
$19.83
Avg / unit
$0.4833
Latest quarter Q1 2026
1.5KRx
Medicaid pays / ea
$0.4833
gross reimbursed
vs
NADAC / ea
$0.2997
acquisition cost
=
Spread
+$0.1836
+61% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
78% FFS 22% MCO
Fee-for-service · 8,302 Rx Managed care · 2,276 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 28,460 units · 496 per 100k residents MN Wisconsin: no data reported WI Michigan: 6,898 units · 68.7 per 100k residents MI New York: 295,685 units · 1,511 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 1,422 units · 33.6 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 3,816 units · 30.4 per 100k residents IL Indiana: 23,114 units · 337 per 100k residents IN Ohio: no data reported OH Pennsylvania: 16,648 units · 128 per 100k residents PA New Jersey: 4,761 units · 51.2 per 100k residents NJ Massachusetts: no data reported MA California: 15,817 units · 40.6 per 100k residents CA Utah: no data reported UT Colorado: 259 units · 4.4 per 100k residents CO Nebraska: 4,892 units · 247 per 100k residents NE Missouri: no data reported MO Kentucky: 25,493 units · 563 per 100k residents KY West Virginia: no data reported WV Virginia: 1,663 units · 19.1 per 100k residents VA Maryland: no data reported MD Connecticut: 1,224 units · 33.8 per 100k residents CT Rhode Island: 1,260 units · 115 per 100k residents RI Arizona: 684 units · 9.2 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: 396 units · 38.4 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 1,466 units · 216 per 100k residents DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.41,511
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 1,511 /100k
2 Kentucky 563 /100k
3 Minnesota 496 /100k
4 Indiana 337 /100k
5 Nebraska 247 /100k
6 D.C. 216 /100k
7 Pennsylvania 128 /100k
8 Rhode Island 115 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GenTeal Tears Moderate Preservative Free (this brand).

Top reported reactions

Blindness2
Ocular Hyperaemia2
Eye Haemorrhage1
Eye Infection1
Eye Pain1
Hypertension1
Infarction1

Reporter sex

3 reports
Male · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.